EA
RMD icon

Emerald Advisers’s ResMed RMD Stock Holding History

Emerald Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-970
Closed -$186K – 263
2024
Q2 		$186K Sell
970
-3,965
-80% -$805K 0.01% 216
2024
Q1 		$977K Sell
4,935
-80
-2% -$14.7K 0.04% 146
2023
Q4 		$863K Buy
5,015
+1,864
+59% +$286K 0.04% 153
2023
Q3 		$466K Buy
3,151
+688
+28% +$124K 0.02% 173
2023
Q2 		$538K Sell
2,463
-36
-1% -$8.02K 0.02% 169
2023
Q1 		$547K Sell
2,499
-15
-0.6% -$3.25K 0.03% 171
2022
Q4 		$523K Sell
2,514
-41
-2% -$9.01K 0.03% 166
2022
Q3 		$558K Buy
+2,555
New +$582K 0.03% 163

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Emerald Advisers's RMD Position: Q3 2024 in Review

Emerald Advisers sold out of ResMed (RMD) in Q3 2024, closing a stake of 970 shares — an estimated $186K sold.

Emerald Advisers first reported a position in RMD in Q3 2022 and held it in 8 quarters. The position peaked at $977K in Q1 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Emerald Advisers reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Emerald Advisers sold 970 ResMed shares in Q3 2024, an estimated $186K.
  • Emerald Advisers first reported a position in ResMed in Q3 2022 and held it in 8 quarters.
  • Emerald Advisers's ResMed position peaked at $977K in Q1 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Emerald Advisers's 13F filing for Q3 2024, filed 29 Oct 2024.